Zealand Pharma CEO: Share sale arms us for partnership negotiations
![Adam Steensberg, CEO of Zealand Pharma | Photo: Zealand Pharma](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14465531.ece/ALTERNATES/schema-16_9/doc7n1kpjr6mco109cgzh9d.jpg)
With strong phase III data from a study of drug candidate glepaglutide in the bag, Zealand Pharma set off on Tuesday to raise capital and did so successfully after a direct share issuance targeting professional investors brought in DKK 786m (USD 105m) on the same day.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Bank hails Zealand Pharma's data as "home run"
For subscribers
Zealand Pharma sells shares for over USD 100m
For subscribers